Patent details

Basic Information

Publication number:

EP3870174

PCT Application Number:

US2019057406

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP198773491

PCT Publication Number:

WO2020086555

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF

French Title of Invention:

PROMÉDICAMENTS ANTIVIRAUX ET NANOFORMULATIONS DE CEUX-CI

German Title of Invention:

ANTIVIRALE PRODRUGS UND NANOFORMULIERUNGEN DAVON

SPC Number:

Dates

Filing date:

22/10/2019

Grant date:

01/11/2023

EP Publication Date:

01/09/2021

PCT Publication Date:

30/04/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/11/2023

EP B1 Publication Date:

01/11/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/10/2024

Expiration date:

22/10/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/10/2023

 

 

Name:

Board of Regents of the University of Nebraska

Address:

Varner Hall 3835 Holdrege Street, Lincoln, NE 68583, United States (US)

Inventor

1

Name:

GENDELMAN, Howard E.

Address:

United States (US)

2

Name:

EDAGWA, Benson

Address:

United States (US)

Priority

Priority Number:

201862748798 P

Priority Date:

22/10/2018

Priority Country:

United States (US)

Classification

IPC classification:

C07D 498/14; A61K 31/5365; A61P 31/18; A61K 47/54; A61K 9/14;

Publication

European Patent Bulletin

Issue number:

202344

Publication date:

01/11/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages